Robert C. Stanton MDPrincipal Investigator in the Section on Vascular Cell Biology and the Chief of the Kidney and Hypertension Section at the Joslin Diabetes Center, Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts
Dr. Stanton is Chief of the Kidney and Hypertension Section at the Joslin Diabetes Center and an Associate Professor of Medicine at Harvard Medical School.
Dr. Stanton has given many invited lectures throughout the world and written many original articles and reviews on clinical and basic science aspects of diabetic kidney disease.
Dr. Stanton serves on the Professional Practice Committee of the American Diabetes Association (ADA Guideline Committee) and is the Chair of the Chronic Kidney Guidelines Section. His research has focused on an essential enzyme that plays a major role in regulating multiple cellular functions, glucose 6-phosphate dehydrogenase (G6PD). His lab has discovered that G6PD is essential for cell survival and dysregulation of G6PD plays an important role in the pathogenesis of many diseases including diabetes mellitus, diabetic kidney disease and diabetic vascular disease.
Dr. Stanton is also very involved with teaching at all levels, and he has received three Honorary Professorships and a major lifetime-achievement teaching award for Sustained Excellence in Teaching from Harvard Medical School.
DisclosuresDr. Stanton has no relevant disclosures.
Recent Contributions to PracticeUpdate:
- Major CV Events and Subsequent Risk of Kidney Failure With Replacement Therapy
- Association of Diabetes-Related Kidney Disease With Cardiovascular and Non-Cardiovascular Outcomes
- Incidence of ESRD With Type 1 Diabetes Diminishes Over Time
- Combined Diabetes–Renal Multifactorial Intervention in Advanced Diabetic Nephropathy